Interface Biologics
200 Front St. W., Suite 3004
P.O. Box 31
Toronto
Ontario
M5V 3K2
Canada
Tel: 416-597-1428
Fax: 416-598-3328
Website: http://www.interfacebiologics.com/
Email: info@interfacebiologics.com
9 articles about Interface Biologics
-
AngioDynamics Extends Licensing Agreement With Interface Biologics to Include Central Venous Catheters (CVCs)
9/23/2013
-
Interface Biologics Announces $7M Financing
1/10/2011
-
Interface Biologics-BASF Future Business Collaborate
1/4/2011
-
Interface Biologics Receives ISO 13485:2003 Certification
10/26/2010
-
Interface Biologics, Fresenius Medical Care Sign License Agreement
7/20/2010
-
Interface Biologics Secures $5M Financing and Appoints Thomas P. Reeves President and Chief Executive Officer
12/9/2008
-
Interface Biologics' Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coating
9/16/2008
-
Interface Biologics Announces Dr. Nicolas Chronos, M.D. to its Advisory Board
8/20/2007
-
Interface Biologics Announce Addition of Dr. Robert Schwartz, M.D. to its Advisory Board
5/9/2007